Cargando…
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
PURPOSE: This retrospective analysis focuses on treatment stage migration in patients with hepatocellular carcinoma (HCC) to identify successful treatment sequences in a large cohort of real-world patients. METHODS: 1369 HCC patients referred from January 1993 to January 2020 to the tertiary center...
Autores principales: | Wehling, Cyrill, Dill, Michael T., Olkus, Alexander, Springfeld, Christoph, Chang, De-Hua, Naumann, Patrick, Longerich, Thomas, Kratochwil, Clemens, Mehrabi, Arianeb, Merle, Uta, Pfeiffenberger, Jan, Rupp, Christian, Weiss, Karl Heinz, Mieth, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236446/ https://www.ncbi.nlm.nih.gov/pubmed/33537908 http://dx.doi.org/10.1007/s00432-021-03528-3 |
Ejemplares similares
-
Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
por: Mohr, Isabelle, et al.
Publicado: (2022) -
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
por: Vogeler, Marie, et al.
Publicado: (2020) -
SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study
por: Rauber, Conrad, et al.
Publicado: (2021) -
Surgical management of primary liver cancers during the COVID-19 pandemic: overcoming the dilemma with standardization
por: Ramouz, Ali, et al.
Publicado: (2023) -
Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma
por: Lozanovski, Vladimir J., et al.
Publicado: (2019)